ArticleCancer letters2024

Corrigendum to "Pin1 inhibition reverses the acquired resistance of human hepatocellular carcinoma cells to Regorafenib via the Gli1/Snail/E-cadherin pathway" [Cancer Lett. 444 (2019) 82-93].

Jichuang Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.